Back to calendar
Tarsus Pharmaceuticals, Inc. (TARS) Earnings
TARS reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.18
Actual EPS: $-0.16
EPS surprise: 60.03%
Company overview
Market Cap$2.4B
PriceUSD 56.11
EPS (TTM)-1.13
52-week high85.25
52-week low38.51
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees370